In recent years, Imeik has intensified R&D investment in biomedical polymers, recombinant proteins, and tissue engineering technologies. Aligning with clinical advancements and industry trends, we continuously innovate in technology, materials, and product formulations. Through proprietary R&D, collaborative development, strategic investments, and licensed technologies, we expand into comprehensive treatment solutions—extending our product pipeline from medical aesthetics to life science—to deliver tailored, premium products for diverse needs.

Our development portfolio features a tiered structure spanning medical aesthetics, metabolic disease treatment, and general surgery. We are advancing multiple product categories, including botulinum toxins, weight/fat management, energy-based devices, collagen therapies, and post-operative recovery. These products will progressively launch upon regulatory approval to enhance life quality through integrated solutions.